PCCAB has been involved in research for since 2005, and established a dedicated research department in 2008.
PCCAB is unique in that it can offer trials and recruitment at many different sites. Principal investigators are situated at multiple locations allowing us to determine the most appropriate central location for each trial. By referring patients to trials within our own practice we ensure maximal recruitment and patient satisfaction.
Because of our large patient pool we typically recruit patients from our own practice. This has led to a detailed prescreening process, leading to few screenfails and maximum enrollment. Since 2008 we have maintained patients in our studies of up to 5 years at a rate of over ninety-five percent.
Principal Investigators include:
Sponsors and Collaborators
Since 2008 we have conducted over 80 trials as part of NIH consortiums, (NHLBI, and NIA), and from over 30 different pharmaceutical and device companies.